Image name
Image name
Image name

Tianjin Olive Biotechnology Co., Ltd.

Tianjin Olive Biotechnology Co., Ltd., located in the TEDA Modern Industrial Zone, Binhai New Area, Tianjin, is a company integrating the research and development, production, and sales of nucleosides, nucleotides and their derivatives, fluorescein, and core raw materials for gene sequencing. Olive has now established a fully DCS-controlled automated production facility and strictly adheres to ISO9001, ISO14001, and ISO45001 management standards. The company meticulously controls every stage—from raw material procurement and process monitoring to finished-product testing, environmental protection, and production safety—ensuring high-quality and stable supply to meet customer needs and offering customized supply services tailored to specific client requirements. The company’s testing center is CNAS-accredited and boasts a domestically leading platform for chemical modification and purification of nucleosides. Our products find applications in areas such as molecular diagnostics, gene sequencing, small nucleic acid therapeutics, and mRNA vaccines/drugs.
Dr. Ma Long, founder of Olive, graduated from the School of Medicine at Peking University and earned a PhD in the UK. He has extensive R&D experience in the development of small-molecule innovative drugs and nucleoside chemistry. The R&D team led by Dr. Ma Long has successfully developed multiple nucleoside and nucleotide products and has achieved their industrial-scale production.
Tianjin Lianlong New Materials Co., Ltd. (stock code: 300596) is the controlling shareholder of Olive. Leveraging Lianlong’s strengths in engineering design, large-scale plant construction, production management, and quality control in the field of fine chemical manufacturing, Olive aims to use its nucleic acid drug raw materials and biofluorescent probe detection product lines as a starting point for development, gradually evolving into a world-class, high-tech biopharmaceutical testing reagent platform.